A purple and pink letter v on a white background.
September 21, 2018

What Is PEMF and Why Is It Useful in Medical Aesthetics?

The field of medical aesthetics is constantly evolving, with new techniques and technologies being developed and tested as the next top medical aesthetics treatment trend each year. Alternatively, technologies that have been used for decades may regain favor as they evolve or are adopted from other industries. Pulsed Electro Magnetic Fields (PEMF) is one of those technologies. But what is PEMF and why is it useful in medical aesthetics?

The History of PEMF Use

Historically, Pulsed Electro Magnetic Fields have been widely used for therapeutic treatments including those for bone growth, wound healing, depression, nerve and muscle pain relief, and the regeneration of musculoskeletal tissue (i.e., cartilage, tendons, and ligaments). While PEMF therapy was common around the 1950s, the United States Food and Drug Administration (FDA) only granted approvals for the use of PEMF starting in 1979 for bone growth.

In terms of the delivery of PEMF therapy, the first PEMF devices featured the Helmholtz coil. Treatments required patients to be placed inside the device that generated and delivered the therapeutic magnetic field. Today, PEMF therapy devices are much more compact. Tabletop devices often feature an applicator containing coils that deliver magnetic pulses, while other devices resembling a yoga mat are used with massage tables and deliver the treatment as the patient lies on the device.

How Does PEMF Work?

PEMF treatments work in a multitude of ways, which explains why this technology is used in a variety of medical fields. In terms of bone growth, PEMF supports osteoblast formation to prompt healthy bone formation, while disturbing osteoclast formation to prevent degradation. In sports therapy, PEMF has positive effects on the regeneration of damaged musculoskeletal tissues, with one study showing a significant improvement in pain, mobility, and daily activity via its support of the healthy production of collagen and fibroblasts. Essentially, these building blocks—collagen and fibroblasts—help to spur the healthy repair of damaged tendons, muscles, and ligaments on a cellular level, while recharging tired and damaged cells so that they may perform to their top potential.

But what’s at the root of these effects? How is the therapy delivered to damaged cells? Simply put, PEMF therapy delivers low-level electro magnetic radiation bursts to stimulate cells. While these electro magnetic levels are low and similar to what the body faces on a regular basis, it’s the delivery in pulses of five to 30 hertz that spurs cells to react. These electro magnetic pulses penetrate deep within the skin to activate and energize cells and kickstart their natural repair cycles, replicating and producing healthier cells in the process.

The Benefits of PEMF in Medical Aesthetics

PEMF’s effects on collagen and fibroblast production levels make it ideal for medical aesthetics treatments. In fact, advanced radio frequency (RF) technology combined with PEMF offers optimal results in medical aesthetics treatments, including non-invasive cellulite reduction, body contouring, and skin tightening. In these combination therapies, RF pulses are delivered in phases to homogeneously maintain optimal temperatures while delivering heat deep below the skin’s surface for maximum efficacy.  

Meanwhile, PEMF delivers quick pulses of electricity via a coil placed over the targeted treatment area, inducing magnetic fields through the skin that alter the electrical charge of dermal cells. This results in an increase in collagen production via dermal fibroblasts and the stimulation of angiogenesis for healthy cell renewal. The combined delivery of RF and PEMF stimulates neovascularity, fibroblast proliferation, collagen synthesis, and the contraction of elastin fibers for smoother, firmer, healthier-looking skin.  

Interested in learning more about RF and PEMF-powered medical aesthetics devices? Consider Venus Concept’s selection of compact, easy-to-use devices featuring today’s most advanced technology with proven results. As more medical aesthetics devices look to incorporate PEMF, Venus Concept’s line of devices featuring patented (MP) 2 technology, which combines Multi-Polar RF and PEMF, offer the advantage of no disposables and an industry-first subscription acquisition model that puts our customers’ success first.

Contact an expert today to learn more about the advantages of a Venus Concept partnership alongside an industry-leading medical aesthetics device featuring PEMF.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.